is retatrutide on the market yet Warning issued over counterfeit weight-loss drugs labelled as retatrutide

New project announcement: HHS‑OIG is taking a closer look at FDA's oversight of compounded GLP‑1 drugs. Although shortages ended in 2025, some facilities may still be producing these drugs at scale. Our

27.23

★★★★☆5.0 (288)

FDA issued 25 warning letters to telehealth companies for false and misleading claims about compounded GLP-1 products. Unlike FDA-approved drugs, these products have not been proven to be safe, effective, or of

27.15

★★★★★4.9 (35)

Report: FDA must enforce rules on compounded GLP-1s

27.04

★★★★★4.6 (112)

Structure of GLP-1 (7–36) amide

20.88

★★★★★4.1 (61)

Buyer beware. New data points to a higher likelihood of adverse events from using compounded GLP-1 meds versus the fda approved branded versions. No I dong get paid by these companies. In fact the

25.32

★★★★★5.0 (68)

GLP-1 Agonists: Managing Employee Health and Employer Costs

29.84

★★★★★4.8 (85)

Compounded" GLP-1 drugs | Health Communication Research Laboratory

22.75

★★★★★4.4 (141)